Andrew Arno - Apr 3, 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Andrew Arno
Stock symbol
OCX
Transactions as of
Apr 3, 2023
Transactions value $
$150,001
Form type
4
Date filed
4/5/2023, 09:29 PM
Previous filing
Jan 31, 2023
Next filing
Jun 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $50K +141K +26.52% $0.35 673K Apr 3, 2023 Direct
transaction OCX Common Stock, no par value Award $50K +141K +940.56% $0.35 156K Apr 3, 2023 See footnote F1
transaction OCX Common Stock, no par value Award $50K +141K +940.56% $0.35 156K Apr 3, 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock, no par value ("Common Stock"), are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and in such capacity has the right to vote and dispose of securities held by JBA.
F2 These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and in such capacity has the right to vote and dispose of securities held by MJA.